Multiparametric MRI Expedites Treatment in Muscle-Invasive Bladder Cancer
By Elana Gotkine HealthDay Reporter
FRIDAY, Jan. 24, 2025 -- Incorporating multiparametric magnetic resonance imaging (mpMRI) for initial staging can reduce the time to correct treatment (TTCT) for patients with muscle-invasive bladder cancer (MIBC), according to a study published online Jan. 14 in the Journal of Clinical Oncology.
Richard T. Bryan, Ph.D., from the University of Birmingham in the United Kingdom, and colleagues conducted a prospective open-label randomized study within 17 U.K. hospitals involving patients with suspected new bladder cancer who were randomly assigned to transurethral resection of bladder tumor (TURBT)-staged or mpMRI-staged care to examine whether treatment could be expedited for MIBC with mpMRI.
A total of 638 patients were screened between May 31, 2018, and Dec. 31, 2021, and 143 were randomly assigned to TURBT or initial mpMRI (72 and 71, respectively). Thirty-six of 39 participants with suspected MIBC underwent mpMRI for feasibility. The researchers found that for participants with MIBC, the median TTCT was significantly shorter with initial mpMRI (53 days versus 98 days for TURBT). No detriment was seen for participants with non-MIBC (median TTCT, 17 days for mpMRI versus 14 days for TURBT). There were no reports of serious adverse events.
"Incorporating mpMRI ahead of TURBT into the standard pathway was beneficial for all patients with suspected MIBC. TURBT could be avoided in a proportion of these patients," the authors write. "This approach can improve decision-making and accelerate time to treatment."
Several authors disclosed ties to the biopharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted January 2025
Read this next
32 Percent of U.S. Adults Consumed Fast Food on a Given Day in 2021 to 2023
FRIDAY, June 27, 2025 -- Over 30 percent of adults and children consumed fast food on a given day during August 2021 to August 2023, according to two reports from the National...
Disparities Seen in Continuous Glucose Monitor Rx by Language Preference
FRIDAY, June 27, 2025 -- For patients with type 2 diabetes (T2D), disparities in continuous glucose monitor (CGM) prescriptions are seen by language preference, with less access...
Survey Shows Few Adults Recognize Testicular Cancer as Affecting Young Men
FRIDAY, June 27, 2025 -- Only one in 10 U.S. adults correctly identified testicular cancer as most commonly affecting men under age 40, according to a survey released June16 by...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.